Orlando Clinical Research Center
Orlando Clinical Research Center
Orlando, Florida, United States14 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 | 2026-10-09 | NCT07741604 | |
| A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems | Healthy; Hepatic Impairment | Recruiting | Phase 1 | 2026-10-05 | NCT07023354 | |
| Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib | Healthy; Hepatic Impairment | Recruiting | Phase 1 | 2026-09-21 | NCT06997276 | |
| A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib | Hepatic Impairment | Recruiting | Phase 1 | 2026-09-18 | NCT07144111 | |
| A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease | Digestive System Diseases, Hepatic Insufficiency, liver disorder | Recruiting | Phase 1 | 2026-08-21 | NCT07677358 | |
| A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function | Healthy; Hepatic Impairment | Recruiting | Phase 1 | 2026-07-23 | NCT07269301 | |
| A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment | Digestive System Diseases, Hemic and Lymphatic Diseases, Hepatic Insufficiency, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, liver disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 1 | 2026-06-16 | NCT07559474 | |
| A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 | 2026-06-16 | NCT07559396 | |
| Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants | Normal Hepatic Function; Severe Hepatic Impairment | Recruiting | Phase 1 | 2026-06-05 | NCT07250633 | |
| A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers. | Digestive System Diseases, Hepatic Insufficiency, liver disorder | Recruiting | Phase 1 | 2026-06-04 | NCT07401862 | |
| A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 1 | 2026-05-12 | NCT07315360 | |
| A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function | Healthy | Recruiting | Phase 1 | 2026-04-23 | NCT07519135 | |
| A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function | Healthy Participants | Recruiting | Phase 1 | 2026-04-03 | NCT07231991 | |
| Clofutriben Pharmacokinetics in Patients With Impaired Renal Function | Moderate Renal Impairment | Recruiting | Phase 1 | 2025-12-23 | NCT07227922 |